EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Characterization of antibody response to SARS-CoV-2 Orf8 from three waves of COVID-19 outbreak in Thailand

Jeeraphong Thanongsaksrikul iD, Paskorn Sritipsukho iD, Potjanee Srimanote, Onruedee Khantisitthiporn, Wipawadee Sianglum, Uayporn Pinitchai, Yong Poovorawan

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0297272 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Jeeraphong Thanongsaksrikul und 6 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Program in Biomedical Sciences, Faculty of Allied Health Sciences, Thammasat University, Pathumthani, Thailand. Hauptthemen laut MEDLINE: COVID-19, Antibodies, Viral, SARS-CoV-2, Immunoglobulin G. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Research Council of Thailand, Thammasat University, Thammasat University Research Unit in Molecular Pathogenesis and Immunology of Infectious Diseases, Thammasat University..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A dynamic of virus adaptation and a mass vaccination campaign could significantly reduce the severity of clinical manifestations of COVID-19 and transmission. Hence, COVID-19 may become an endemic disease globally. Moreover, mass infection as the COVID-19 pandemic progressed affected the serology of the patients as a result of virus mutation and vaccination. Therefore, a need exists to acquire accurate serological testing to monitor the emergence of new outbreaks of COVID-19 to promptly prevent and control the disease spreading. In this study, the anti-Orf8 antibodies among samples collected in Thailand’s first, fourth, and fifth waves of COVID-19 outbreaks compared with pre-epidemic sera were determined by indirect ELISA. The diagnostic sensitivity and specificity of the anti-Orf8 IgG ELISA for COVID-19 samples from the first, fourth, and fifth waves of outbreaks was found to be 100% compared with pre-epidemic sera. However, the diagnostic sensitivity and specificity of the anti-Orf8 IgG ELISA for a larger number of patient samples and controls from the fifth wave of outbreaks which were collected on day 7 and 14 after an RT-PCR positive result were 58.79 and 58.44% and 89.19 and 58.44%, respectively. Our data indicated that some of the controls might have antibodies from natural past infections. Our study highlighted the potential utility of anti-Orf8 IgG antibody testing for seroprevalence surveys but still warrants further investigations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Antibodies, ViralSARS-CoV-2Immunoglobulin GDisease OutbreaksEnzyme-Linked Immunosorbent AssayHumansThailandAdultFemaleViral ProteinsMaleMiddle AgedSensitivity and SpecificityAgedCOVID-19 Serological TestingAntibody Formation

Substanzen

Antibodies, ViralImmunoglobulin GViral ProteinsORF8 protein, SARS-CoV-2

Autor:innen und Institutionen

  • Graduate Program in Biomedical Sciences, Faculty of Allied Health Sciences, Thammasat University, Pathumthani, Thailand.
  • Thammasat University Research Unit in Molecular Pathogenesis and Immunology of Infectious Diseases, Thammasat University, Pathumthani, Thailand.
  • Healthcare Service Center, Faculty of Allied Health Sciences, Thammasat University, Pathumthani, Thailand.
  • Center of Excellence in Applied Epidemiology, Thammasat University, Pathumthani, Thailand.
  • Department of Pediatrics, Faculty of Medicine, Thammasat University, Pathumthani, Thailand.
  • Department of Medical Technology, Faculty of Allied Health Sciences, Thammasat University, Pathumthani, Thailand.

ORCID-Profile: Jeeraphong Thanongsaksrikul, Paskorn Sritipsukho

Förderung

  • the National Research Council of Thailand
  • Thammasat University
  • Thammasat University Research Unit in Molecular Pathogenesis and Immunology of Infectious Diseases, Thammasat University.
  • Center of Excellence in Applied Epidemiology, Thammasat University.

Zitieren

APA

Thanongsaksrikul, J., Sritipsukho, P., Srimanote, P., Khantisitthiporn, O., Sianglum, W., Pinitchai, U., & Poovorawan, Y. (2024). Characterization of antibody response to SARS-CoV-2 Orf8 from three waves of COVID-19 outbreak in Thailand. PLOS ONE. https://doi.org/10.1371/journal.pone.0297272

Vancouver

Thanongsaksrikul J, Sritipsukho P, Srimanote P, Khantisitthiporn O, Sianglum W, Pinitchai U, et al. Characterization of antibody response to SARS-CoV-2 Orf8 from three waves of COVID-19 outbreak in Thailand. PLOS ONE. 2024. doi:10.1371/journal.pone.0297272

BibTeX
@article{Thanongsaksrikul2024,
  author = {Thanongsaksrikul, Jeeraphong and Sritipsukho, Paskorn and Srimanote, Potjanee and Khantisitthiporn, Onruedee and Sianglum, Wipawadee and Pinitchai, Uayporn and Poovorawan, Yong},
  title = {Characterization of antibody response to SARS-CoV-2 Orf8 from three waves of COVID-19 outbreak in Thailand},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0297272}
}
Kostenlos starten →